News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
45,124 Results
Type
Article (1816)
Company Profile (30)
Press Release (43278)
Section
Business (11880)
Career Advice (69)
Deals (1993)
Drug Delivery (3)
Drug Development (6303)
Employer Resources (3)
FDA (988)
Job Trends (896)
News (20615)
Policy (1499)
Tag
Academia (197)
Adcomms (3)
Allergies (10)
Alliances (2691)
ALS (3)
Alzheimer's disease (100)
Antibody-drug conjugate (ADC) (14)
Approvals (992)
Artificial intelligence (10)
Autoimmune disease (1)
Bankruptcy (15)
Best Places to Work (757)
BIOSECURE Act (5)
Biosimilars (4)
Biotechnology (21)
Bladder cancer (4)
Brain cancer (1)
Breast cancer (10)
Cancer (155)
Cardiovascular disease (17)
Career advice (54)
Career pathing (1)
CAR-T (22)
Cell therapy (58)
Cervical cancer (1)
Clinical research (5110)
Collaboration (45)
Compensation (19)
Complete response letters (1)
COVID-19 (204)
CRISPR (5)
C-suite (18)
Cystic fibrosis (8)
Data (179)
Diabetes (14)
Diagnostics (341)
Drug discovery (5)
Drug pricing (2)
Duchenne muscular dystrophy (1)
Earnings (4851)
Editorial (3)
Employer resources (3)
Events (8577)
Executive appointments (63)
FDA (1079)
Funding (62)
Gene editing (11)
Gene therapy (49)
GLP-1 (48)
Government (174)
Guidances (5)
Healthcare (1347)
IgA nephropathy (3)
Immunology and inflammation (7)
Infectious disease (212)
Inflammatory bowel disease (15)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (4)
Interviews (9)
IPO (1173)
IRA (1)
Job creations (180)
Job search strategy (52)
Kidney cancer (1)
Labor market (4)
Layoffs (17)
Legal (257)
Liver cancer (7)
Lung cancer (27)
Lymphoma (15)
Machine learning (2)
Management (1)
Manufacturing (13)
MASH (1)
Medical device (653)
Medtech (653)
Mergers & acquisitions (847)
Metabolic disorders (30)
Multiple sclerosis (1)
Neurodegenerative disease (6)
Neuroscience (119)
NextGen: Class of 2025 (451)
Non-profit (300)
Now hiring (1)
Obesity (18)
Opinion (3)
Ovarian cancer (1)
Pain (9)
Pancreatic cancer (8)
Parkinson's disease (7)
Patents (14)
Patient recruitment (9)
Peanut (4)
People (3738)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase I (1743)
Phase II (2200)
Phase III (1823)
Pipeline (99)
Policy (11)
Postmarket research (224)
Preclinical (582)
Press Release (3)
Prostate cancer (6)
Radiopharmaceuticals (12)
Rare diseases (26)
Real estate (350)
Recruiting (2)
Regulatory (1208)
Reports (8)
Research institute (157)
Resumes & cover letters (6)
RSV (2)
Schizophrenia (3)
Series A (11)
Series B (3)
Service/supplier (2)
Sickle cell disease (3)
Special edition (2)
Spinal muscular atrophy (5)
Sponsored (6)
Startups (217)
Supply chain (3)
Tariffs (2)
Vaccines (36)
Weight loss (5)
Women's health (1)
Worklife (1)
Date
Last 7 days (65)
Last 30 days (196)
Last 365 days (2610)
2025 (939)
2024 (2726)
2023 (3079)
2022 (4383)
2021 (5195)
2020 (4403)
2019 (3390)
2018 (2229)
2017 (2015)
2016 (1838)
2015 (2122)
2014 (1373)
2013 (1179)
2012 (1253)
2011 (1384)
2010 (1215)
Location
Africa (27)
Arizona (7)
Asia (2546)
Australia (423)
California (510)
Canada (178)
China (44)
Colorado (24)
Connecticut (21)
Delaware (19)
Europe (7256)
Florida (51)
Georgia (6)
Idaho (1)
Illinois (25)
India (2)
Indiana (7)
Japan (18)
Kansas (4)
Kentucky (1)
Maryland (69)
Massachusetts (270)
Michigan (9)
Minnesota (46)
Mississippi (1)
Missouri (53)
Nevada (10)
New Hampshire (6)
New Jersey (97)
New Mexico (1)
New York (82)
North Carolina (66)
Northern California (216)
Ohio (7)
Oklahoma (1)
Oregon (1)
Pennsylvania (133)
Puerto Rico (2)
Rhode Island (2)
South America (55)
Southern California (182)
Tennessee (7)
Texas (57)
United States (1584)
Utah (7)
Virginia (6)
Washington D.C. (2)
Washington State (27)
Wisconsin (2)
45,124 Results for "1st biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
April 28, 2025
·
8 min read
Press Releases
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
May 8, 2025
·
1 min read
Press Releases
Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025
April 30, 2025
·
2 min read
Drug Development
1ST Biotherapeutics, Inc. Announces First Patient Dosed in Phase I/II Study of HPK1 Inhibitor FB849 in Patients with Advanced Solid Tumors
1ST Biotherapeutics, Inc. announced the first patient dosing in the clinical Phase I/II trial evaluating FB849 in patients with advanced solid tumors.
December 14, 2023
·
1 min read
Press Releases
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
February 17, 2025
·
9 min read
Press Releases
FORE Biotherapeutics to Present Plixorafenib Abstract at the 2025 American Society of Clinical Oncology Annual Meeting
April 30, 2025
·
1 min read
Press Releases
Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel)
May 5, 2025
·
6 min read
Press Releases
Interius BioTherapeutics to Present at Upcoming Scientific Meetings
April 17, 2025
·
2 min read
Press Releases
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
April 8, 2025
·
7 min read
1 of 4,513
Next
